We prospectively conducted this analysis in a real-world clinical setting by using strict inclusion and exclusion criteria to ensure the selection of a clinically relevant and homogeneous population, namely adults who were overweight or obese, inadequately controlled T2DM (HbA1c > 7.2%), and no prior exposure to GLP-1 RAs. The gene discussed is GCG; the disease is type 2 diabetes mellitus.